Education
About Us
Working with TipRanks
Follow Us
IMRIS Inc (IMRSQ)
OTHER OTC:IMRSQ
IMRSQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume3.15K
Average Volume (3M)675.74K
Market Cap
$63.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-107.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding62,594,000
10 Day Avg. Volume675,741
30 Day Avg. Volume675,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.81% Other Institutional Investors
99.19% Public Companies and
Individual Investors
IMRSQ FAQ
What was IMRIS Inc’s price range in the past 12 months?
IMRIS Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is IMRIS Inc’s market cap?
IMRIS Inc’s market cap is $63.00.
When is IMRIS Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IMRIS Inc’s earnings last quarter?
Currently, no data Available
Is IMRIS Inc overvalued?
According to Wall Street analysts IMRIS Inc’s price is currently Overvalued.
Does IMRIS Inc pay dividends?
IMRIS Inc does not currently pay dividends.
What is IMRIS Inc’s EPS estimate?
IMRIS Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IMRIS Inc have?
IMRIS Inc has 62,594,000 shares outstanding.
What happened to IMRIS Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IMRIS Inc?
Currently, no hedge funds are holding shares in IMRSQ
Company Description
IMRIS Inc
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.
Technical Analysis
Biodexa Pharmaceuticals
―
Hepion Pharmaceuticals
―
LogicMark
―
Universe Pharmaceuticals
―
Sharps Technology, Inc.
―